Dr. Lecia Sequist is the Program Director of the Cancer Early Detection & Diagnostics Clinic at Mass General Cancer Center. For nearly 20 years, she’s specialized in lung cancer.
Observing first-hand the obstacles involved in current screenings of lung cancer, Dr. Sequist made a career switch to the research of early lung cancer detection. This led her to meet MIT professor, Regina Barzilay. Together, they created Sybil – an open-source AI tool that uses pattern recognition to predict one’s risk of lung cancer.
Dr. Sequist shares the benefits of AI in preventative medicine, how AI works to assess cancer risks, the logistics of using AI, and the importance of getting screened for lung cancer.
🔔 Subscribe to our channel: Stay updated with the latest inspiring stories of Hodgkin Lymphoma patients, empowering information, and support.
✉️ Stay connected: Sign up for our newsletter to receive more inspiring patient stories, the latest medical updates and personalized advice: https://www.thepatientstory.com/newsletter/
Full story and transcript → https://www.thepatientstory.com/medical-experts/ai-lung-cancer-risks/
Comments are closed.